Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|September 1, 2000
High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantationM Mohty, C Faucher, N Vey, et al.
Bone Marrow Transplantation|January 31, 2007
High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantationJ El-Cheikh, C Faucher, S Fürst, et al.
Leukemia & Lymphoma|August 28, 1998
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institutionS Oddou, N Vey, P Viens, et al.
Bone Marrow Transplantation|September 1, 1996
A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignanciesN Vey, B De Prijck, C Faucher, et al.
The New England Journal of Medicine|July 11, 1996
A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du MyélomeM Attal, J L Harousseau, A M Stoppa, et al.
Hematology and Cell Therapy|April 8, 1999
Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvementF Viret, D Blaise, R Bouabdallah, et al.
Leukemia & Lymphoma|September 16, 2011
Efficacy of bendamustine in relapsed/refractory myeloma patients: results from the French compassionate use programG Damaj, F Malard, C Hulin, et al.
Leukemia|June 9, 1999
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patientsR Bouabdallah, A M Stoppa, J F Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphomaA M Stoppa, R Bouabdallah, C Chabannon, et al.
Journal of Viral Hepatitis|December 17, 2009
Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancerP Borentain, P Colson, D Coso, et al.
Pageof 12